Cargando…
Insights into Immune Escape During Tumor Evolution and Response to Immunotherapy Using a Rat Model of Breast Cancer
Animal models are critical for the preclinical validation of cancer immunotherapies. Unfortunately, mouse breast cancer models do not faithfully reproduce the molecular subtypes and immune environment of the human disease. In particular, there are no good murine models of estrogen receptor–positive...
Autores principales: | Gil Del Alcazar, Carlos R., Trinh, Anne, Alečković, Maša, Rojas Jimenez, Ernesto, Harper, Nicholas W., Oliphant, Michael U.J., Xie, Shanshan, Krop, Ethan D., Lulseged, Bethlehem, Murphy, Katherine C., Keenan, Tanya E., Van Allen, Eliezer M., Tolaney, Sara M., Freeman, Gordon J., Dillon, Deborah A., Muthuswamy, Senthil K., Polyak, Kornelia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9177779/ https://www.ncbi.nlm.nih.gov/pubmed/35446942 http://dx.doi.org/10.1158/2326-6066.CIR-21-0804 |
Ejemplares similares
-
Establishing conditions for the generation and maintenance of estrogen receptor-positive organoid models of breast cancer
por: Oliphant, Michael UJ, et al.
Publicado: (2023) -
Combination Therapies to Improve the Efficacy of Immunotherapy in Triple-negative Breast Cancer
por: Alečković, Maša, et al.
Publicado: (2023) -
Breast cancer prevention by short-term inhibition of TGFβ signaling
por: Alečković, Maša, et al.
Publicado: (2022) -
The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2(+) breast cancer
por: Janiszewska, Michalina, et al.
Publicado: (2021) -
RNAi at Oxford
por: Aleckovic, Masa, et al.
Publicado: (2008)